Matches in SemOpenAlex for { <https://semopenalex.org/work/W4212857583> ?p ?o ?g. }
Showing items 1 to 49 of
49
with 100 items per page.
- W4212857583 endingPage "72" @default.
- W4212857583 startingPage "61" @default.
- W4212857583 abstract "Brain metastases(BM)follow the nature of the primary cancer, and understanding the associated genomic abnormalities is essential in the construction of therapeutic strategies for BM. BM showed an excellent response to EGFR-TKI, but the duration of the effect was limited to approximately one year. Despite the longer survival of patients with EGFRm BM, these tumors tended to progress to leptomeningeal carcinomatosis(LMC), and the frequency of central nervous system death was higher than that of tumors without driver mutations. EGFR-TKI also had an effect on LMC and even improved hydrocephalus, but it achieved negative conversion of cancer cells in the cerebrospinal fluid in only limited cases. ALK-TKI also induced a good reduction of BM, and the duration of the response was quite long. Because the expected prognosis of patients after BM in ALK-positive cases is over 5 years, we should choose treatment modalities that are safe in the long term. The dominant cause of death in cancer patients is extracranial progression, and control of extracranial lesions should be prioritized, even in cases with BM. Therefore, the purpose of treatment of BM is to keep patients in a better condition and to maintain the indications for systemic treatment, and molecular-targeted agents, with both the safety and sufficient effectiveness, meet that demand." @default.
- W4212857583 created "2022-02-24" @default.
- W4212857583 creator A5044502022 @default.
- W4212857583 date "2022-01-01" @default.
- W4212857583 modified "2023-09-29" @default.
- W4212857583 title "[Molecular-Targeted Agents as a Novel Therapeutic Tool for Brain Metastases]." @default.
- W4212857583 doi "https://doi.org/10.11477/mf.1436204532" @default.
- W4212857583 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/35169087" @default.
- W4212857583 hasPublicationYear "2022" @default.
- W4212857583 type Work @default.
- W4212857583 citedByCount "0" @default.
- W4212857583 crossrefType "journal-article" @default.
- W4212857583 hasAuthorship W4212857583A5044502022 @default.
- W4212857583 hasConcept C121608353 @default.
- W4212857583 hasConcept C126322002 @default.
- W4212857583 hasConcept C141071460 @default.
- W4212857583 hasConcept C143998085 @default.
- W4212857583 hasConcept C2778134817 @default.
- W4212857583 hasConcept C2779651940 @default.
- W4212857583 hasConcept C3020606620 @default.
- W4212857583 hasConcept C71924100 @default.
- W4212857583 hasConceptScore W4212857583C121608353 @default.
- W4212857583 hasConceptScore W4212857583C126322002 @default.
- W4212857583 hasConceptScore W4212857583C141071460 @default.
- W4212857583 hasConceptScore W4212857583C143998085 @default.
- W4212857583 hasConceptScore W4212857583C2778134817 @default.
- W4212857583 hasConceptScore W4212857583C2779651940 @default.
- W4212857583 hasConceptScore W4212857583C3020606620 @default.
- W4212857583 hasConceptScore W4212857583C71924100 @default.
- W4212857583 hasIssue "1" @default.
- W4212857583 hasLocation W42128575831 @default.
- W4212857583 hasOpenAccess W4212857583 @default.
- W4212857583 hasPrimaryLocation W42128575831 @default.
- W4212857583 hasRelatedWork W10954641 @default.
- W4212857583 hasRelatedWork W12939963 @default.
- W4212857583 hasRelatedWork W1501831 @default.
- W4212857583 hasRelatedWork W2967001 @default.
- W4212857583 hasRelatedWork W372785 @default.
- W4212857583 hasRelatedWork W3781597 @default.
- W4212857583 hasRelatedWork W464974 @default.
- W4212857583 hasRelatedWork W4794094 @default.
- W4212857583 hasRelatedWork W77141 @default.
- W4212857583 hasRelatedWork W8397527 @default.
- W4212857583 hasVolume "50" @default.
- W4212857583 isParatext "false" @default.
- W4212857583 isRetracted "false" @default.
- W4212857583 workType "article" @default.